KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001366244-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
5,876
Total Value
$15,570.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 2,419 | โ | โ | 430,705 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 18, 2026 | Sale | 1,038 | $15.00 | $15,570.00 | 429,667 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 17, 2026 | Exercise/Conversion | 2,419 | $0.00 | $0.00 | 2,419 | Direct | โ | View Details |